Colon Cancer - Cancer center honors TV anchor Robin Roberts - NWITimes.com
Cancer center honors TV anchor Robin Roberts - NWITimes.com
BUFFALO, N.Y. - Robin Roberts has been honored in New York for sharing her cancer treatment experience with millions of television viewers. ABC’s “Good Morning America” co-anchor accepted the 2008 Roswell Park Cancer Institute’s Gilda Radner Courage
Genentech Continues Avastin Colon Study - eNews 2.0
The leading biotechnology company Genentech Inc. said a Phase III study of its drug Avastin focusing on early-stage colon cancer will not be discontinued. The 2,710-patient clinical study, which is carried out by the National Surgical Adjuvant Breast
Genentech continues study of Avastin for early-stage colon cancer - Santa Cruz Sentinel
Biotechnology company Genentech said today it will continue a late-stage study of Avastin focusing on early-stage colon cancer, following an independent safety analysis. The current study involves an Avastin treatment combination with the
Genentech to continue with late-stage study of drug Avastin for early - KTVN.com
SOUTH SAN FRANCISCO, Calif. (AP) - Biotechnology company Genentech Inc. says it will continue with a late-stage study of its drug Avastin for early-stage colon cancer. The announcement today comes after an independent safety analysis of the drug
Key Study Of Genentech’s Avastin Ongoing After Interim Peek - Wall Street Journal
NEW YORK (Dow Jones)–Genentech Inc. (DNA) will continue a key study of blockbuster cancer treatment Avastin in treating early colon cancer, after a third-party interim analysis. The move shouldn’t affect or be considered an indication of the study’s